Trial
NCT04614142
Single Patient Protocol for Donor HCV-positive to Recipient HCV-negative Kidney Transplant in a Patient at Risk for Loss of Dialysis Access
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Massachusetts General Hospital
Collaborators
—
Condition
End Stage Renal Disease
Intervention
Glecaprevir / Pibrentasvir Oral Tablet [Mavyret]
Why stopped
Single patient the protocol was written for consented to another study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-08